{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-145685","form_type":"8-K","ticker":"OMER","cik":"0001285819","company_name":"OMEROS CORP","filed_at":"2021-12-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.906962+00:00","generated_at":"2026-06-28T04:04:56.026834+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Omeros sells OMIDRIA franchise to Rayner Surgical for $125M upfront plus milestones and royalties","bullets":["Upfront payment of $125M at closing; potential $200M milestone if separate payment secured for four continuous years.","Royalties: 50% of U.S. net sales until earlier of Jan 1, 2025 or milestone paid, then 30%; 15% on ex-U.S. net sales.","Transaction valued in excess of $1 billion including royalties; Omeros retains $34M accounts receivable.","Omeros to focus on complement franchise of MASP-2 and MASP-3 inhibitors.","Closing expected on or before Dec 31, 2021, subject to HSR waiting period expiration."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-145685","json":"https://secwatch.observer/filing/0001104659-21-145685.json","markdown":"https://secwatch.observer/filing/0001104659-21-145685.md","text":"https://secwatch.observer/filing/0001104659-21-145685.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1285819/000110465921145685/0001104659-21-145685-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1285819/000110465921145685/tm2134414d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T04:04:56.026834+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}